A real-world study of use of nivolumab in patients with stage III/IV melanoma
Latest Information Update: 22 Nov 2021
At a glance
- Drugs Nivolumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Expanded access
- 22 Nov 2021 New trial record